New Jersey Healthcare Layoffs: Hundreds of Jobs Cut at Major Firms

Novartis, Labcorp, Reckitt Benckiser and others trim staff amid industry restructuring

Apr. 11, 2026 at 5:27am

Got story updates? Submit your updates here. ›

A translucent X-ray photograph revealing the intricate internal components of a medical diagnostic device, conceptually illustrating the complex systems that underpin healthcare delivery.As healthcare companies restructure to boost efficiency, the human impact on patient care remains a critical concern.Parsippany Today

Nearly 300 healthcare roles in New Jersey are set to disappear this year as major players like Novartis, Labcorp, Reckitt Benckiser, RB Health, and Mead Johnson Nutrition cut staff in the name of efficiency, restructuring, and repositioning for a shifting market. The layoffs signal a broader recalibration of who delivers care, where it happens, and how the healthcare economy values certain kinds of labor.

Why it matters

These layoffs are not just about job losses, but raise concerns about the quality and accessibility of patient-facing services. If the workforce in critical support roles shrinks or reorganizes, it could lead to longer wait times, fewer in-person follow-ups, and more reliance on automation and digital channels, potentially trading personalized care for more scalable but less personalized experiences.

The details

Novartis is cutting 114 roles as part of a four-year restructuring aimed at saving $1 billion and sustaining 4% annual sales growth. The company says this shift is toward 'areas where we can create greatest potential impact for patients and customers.' Labcorp plans to cut 83 jobs at its Raritan lab and logistics hub, reflecting how diagnostic networks are being organized for resilience in a market that prizes speed and reliability. Reckitt Benckiser, RB Health and Mead Johnson Nutrition will eliminate nearly 100 positions at their Parsippany headquarters, underscoring how the health economy is treating consumer health, nutrition, and clinical diagnostics as interconnected spheres.

  • Novartis layoffs will occur between June and November 2026.
  • Labcorp layoffs will begin in March 2026 and run through August 2026.
  • Reckitt Benckiser, RB Health and Mead Johnson Nutrition layoffs will begin in March 2026 and run through August 2026.

The players

Novartis

A global pharmaceutical company that is cutting 114 roles as part of a four-year restructuring.

Labcorp

A major diagnostic testing network that is cutting 83 jobs at its Raritan lab and logistics hub.

Reckitt Benckiser

A consumer goods conglomerate that is eliminating nearly 100 positions at its Parsippany headquarters, including its RB Health and Mead Johnson Nutrition subsidiaries.

Got photos? Submit your photos here. ›

What they’re saying

“We must shift toward areas where we can create greatest potential impact for patients and customers.”

— Novartis

What’s next

The companies have not provided details on specific next steps, but industry experts expect continued restructuring and workforce optimization efforts across the healthcare sector as firms adapt to changing market dynamics.

The takeaway

These layoffs signal a broader trend of healthcare labor markets becoming more volatile and strategically segmented, as companies pursue cost savings and operational efficiency. The risk is that this could compromise the human empathy at the core of healthcare, as patient experience, access and outcomes become more tightly linked to corporate dashboards and restructuring cycles.